Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|November 30, 2020
Different Clinical Presentations and Outcomes of Disseminated Varicella in Children With Primary and Acquired ImmunodeficienciesPaul Bastard, Aurélien Galerne, Alain Lefevre-Utile, et al.International Journal of Cancer|December 21, 2010
Childhood Hodgkin's lymphoma, non-Hodgkin's lymphoma and factors related to the immune system: the Escale Study (SFCE)Jérémie Rudant, Laurent Orsi, Alain Monnereau, et al.Genes, Chromosomes & Cancer|June 17, 2009
WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?Marie Corbin, Aurélien de Reyniès, David S Rickman, et al.Haematologica|October 7, 2008
Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcomePaola Ballerini, Judith Landman-Parker, Jean Michel Cayuela, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.Blood|August 30, 2008
Activating mutations in human acute megakaryoblastic leukemiaSébastien Malinge, Christine Ragu, Veronique Della-Valle, et al.British Journal of Haematology|February 22, 2017
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groupsAnanth G Shankar, Gaelle Roques, Amy A Kirkwood, et al.British Journal of Haematology|February 18, 2026
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world studyMarlène Pouthier, Nathalie Garnier, Amaury Leruste, et al.Blood|October 21, 2017
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemiaArnaud Petit, Amélie Trinquand, Sylvie Chevret, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumoursHervé Rubie, Birgit Geoerger, Didier Frappaz, et al.Pageof 7